70 articles with AliveCor
GE Healthcare, AliveCor Partnership Aims to Increase Convenience for Patients and Help Reduce Cardiac-Related Hospitalizations by Improving the Quality and Integration of Patient Data
GE Healthcare and AliveCor announced a partnership to deliver medical-grade six-lead electrocardiograms taken by patients on an AliveCor KardiaMobile 6L ECG device outside of the hospital setting – at home or on the go – directly into GE Healthcare’s MUSE Cardiac Management System for physicians to view and evaluate.
AliveCor, the leading innovator in FDA-cleared personal electrocardiogram technology, announced the appointment of Patricia Baran as Senior Vice President, Healthcare Americas.
1/14/2022Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
AliveCor announced the addition of four new leaders to the company's executive team: Vincent Balsamo as Executive Vice President of Worldwide Sales, Dr. Archana Dubey as Chief Clinical Officer, Dr. Ben Green as Senior Vice President of Services, and Jessica Weinstein as Senior Vice President of Marketing.
AliveCor Acquires CardioLabs and Sets the Stage for the Launch of Advanced Ambulatory Monitoring Services
AliveCor , the global leader in FDA-cleared personal electrocardiogram (ECG) technology and services, today announced that it has acquired the independent diagnostic testing facility (IDTF) CardioLabs, a leading monitoring and cardiac diagnostic service provider.
AliveCor, a leading innovator in FDA-cleared personal electrocardiogram technology and services, announced that the US International Trade Commission issued a Notice of Institution of an Investigation into Apple's alleged infringement of three AliveCor patents.
AliveCor, the global leader in FDA-cleared personal electrocardiogram technology and services, announced the appointment of Clyde Hosein as its Chief Financial Officer.
AliveCor Announces Collaboration with AstraZeneca to Develop Non-Invasive Potassium Monitoring Solutions
AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced a new collaboration with AstraZeneca
AliveCor, the global leader in FDA-cleared personal electrocardiogram technology, launched an expanded range of ECG determinations on its KardiaMobile devices.
11/25/2020Find out which biopharma companies are raking in cash this week, as companies from around the globe provide updates on their financing rounds and IPOs.
OMRON Strengthens Engagement with AliveCor with Series E Investment, Reinforces Cross-company Alliance for Remote Cardiovascular Condition Management
OMRON Healthcare Co., Ltd. announced on November 24 additional investment into AliveCor by its parent company, OMRON Corporation, as part of $65 million series E funding for the leader in AI-based personal electrocardiogram technology.
AliveCor , the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced that the US FDA had given clearance to the company's next generation of interpretive ECG algorit
AliveCor Closes $65 Million Financing to Accelerate Growth of Its Remote Cardiology Platform For Consumers, Employers, and Providers.
Series-E Round led by existing investors OMRON, Khosla Ventures, WP Global Partners, Qualcomm Ventures and Bold Capital
New subscription service, KardiaCare, helps users manage heart conditions, understand symptoms, and reduce risk for heart disease
AliveCor , the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced a strategic collaboration with the Clifford Lab at Emory University School of Medicine , and the Geor
Medable, Inc. , the leading global platform for decentralized clinical trials, and AliveCor , the leader in AI-based, personal ECG technology, today announced a partnership to dramatically scale remote clinical trials by enabling in-home ECGs with AliveCor’s KardiaMobile6L, the world’s only FDA-cleared six-lead personal ECG. As
World's only FDA-cleared six-lead personal ECG will be used by healthcare professionals to monitor QT duration in patients receiving medications that can cause potentially life threatening QT prolongation.
AliveCor, the leader in AI-based, personal ECG technology, and provider of enterprise cardiology solutions, today announced the appointment of Siva Somayajula, as its Chief Technology Officer.
The company expands its personalized, mobile ECG now to over 25 countries around the world
AliveCor Appoints Priya Abani as Chief Executive Officer; Elevates Vinod Khosla to Chairman of the Board
AliveCor, the leader in FDA-cleared consumer electrocardiogram technology, announced the appointment of Priya Abani as Chief Executive Officer.